Traynor Capital Management, Inc. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Traynor Capital Management, Inc. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2021$2,932,000
+25.9%
26,195
+75.3%
0.40%
+23.7%
Q2 2021$2,329,000
+703.1%
14,947
+526.4%
0.32%
+577.1%
Q1 2021$290,000
-19.4%
2,386
+1.3%
0.05%
-25.0%
Q4 2020$360,000
+69.8%
2,355
+2.6%
0.06%
+30.6%
Q3 2020$212,000
-24.3%
2,295
-66.5%
0.05%
-44.3%
Q3 2019$280,000
-9.1%
6,845
+5.8%
0.09%
-12.0%
Q2 2019$308,0006,4700.10%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders